CTLA4 and melanoma: In contrast to IFNγR1KD melanomas, IFNγR1KO melanomas show a reduced abundance of CD8+ T cells at the baseline and lack increased infiltration and functional rejuvenation of TILs upon anti-CTLA-4 therapy.